-
521
Acetylation of E2F1 at K125 facilitates cell apoptosis under serum stress
Published 2025-02-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
522
Editorial: Advances in immunotherapy of hepatic-biliary-pancreatic cancers, volume II
Published 2025-01-01Subjects: Get full text
Article -
523
HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells
Published 2025-02-01Subjects: Get full text
Article -
524
Acute kidney injury is associated with liver-related outcomes in patients with hepatitis B virus infection: a retrospective cohort study
Published 2025-01-01Subjects: Get full text
Article -
525
Screening and Early Diagnosis of Hepatocellular Cancer and Optimization of Diagnostic Imaging Techniques: A Review and Conclusion of the Expert Panel
Published 2023-02-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
526
Hepatoma cell-derived exosomal SNORD52 mediates M2 macrophage polarization by activating the JAK2/STAT6 pathway
Published 2025-01-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
527
Stellettin B Isolated from Stelletta Sp. Reduces Migration and Invasion of Hepatocellular Carcinoma Cells through Reducing Activation of the MAPKs and FAK/PI3K/AKT/mTOR Signaling Pathways
Published 2022-01-01“…Hepatocellular carcinoma (HCC) is one of the most common malignant tumors, and there is currently a lack of effective treatment options to control the metastasis. …”
Get full text
Article -
528
The Prognostic Value of CRP/Alb Ratio in Predicting Overall Survival for Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Combined with Molecular-Targeted Agents and PD-1/PD-L1 Inhibitors
Published 2025-01-01“…Xiaoyu Huang, Gang Peng, Yaqing Kong, Xiaojing Cao, Xiang Zhou Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of ChinaCorrespondence: Xiang Zhou, Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of China, Email zhou.xiang@yeah.netPurpose: This study aimed to evaluate the prognostic value of C-reactive protein to albumin (CRP/Alb) ratio in hepatocellular carcinoma (HCC) treated with transcatheter intra-arterial therapy combined with molecular targeted agents (MTAs) and programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors.Methods: Medical records of 271 consecutive patients with HCC receiving this combination therapy in China between 2019 and 2023 were retrospectively analyzed. …”
Get full text
Article -
529
Ultrasound-guided percutaneous microwave ablation for metabolic-associated fatty liver disease-related hepatocellular carcinoma (HCC) versus hepatitis virus B-related HCC: a propensity score matching study
Published 2024-12-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
530
Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients
Published 2015-01-01“…To evaluate safety and immune responses of personalized peptide vaccination (PPV) for hepatitis C virus- (HCV-) positive advanced hepatocellular carcinoma (HCC). Patients and Methods. Patients diagnosed with HCV-positive advanced HCC were eligible for this study. …”
Get full text
Article -
531
CircUCK2(2,3) promotes cancer progression and enhances synergistic cytotoxicity of lenvatinib with EGFR inhibitors via activating CNIH4–TGFα–EGFR signaling
Published 2025-01-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
532
PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching Study
Published 2025-01-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
533
Circle-seq reveals that eccDNA may be a key blood biomarker for HBV-associated liver cancer
Published 2025-01-01Subjects: Get full text
Article -
534
-
535
Computer analysis of regulation of hepatocarcinoma marker genes hypermethylated by HCV proteins
Published 2023-01-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
536
Evaluation of the role of unconventional prefoldin RPB5 interactor (URI1) in hepatitis B virus infection
Published 2025-01-01Subjects: Get full text
Article -
537
Thermal ablation enhances immunotherapeutic effect of IP-001 on orthotopic liver cancer in a rat model
Published 2024-12-01Subjects: Get full text
Article -
538
MicroRNA-3145 as a potential therapeutic target for hepatitis B virus: inhibition of viral replication via downregulation of HBS and HBX
Published 2025-01-01Subjects: Get full text
Article -
539
A Machine Learning Model for Predicting Prognosis in HCC Patients With Diabetes After TACE
Published 2025-01-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
540
Autoregulatory Feedback Mechanism of P38MAPK/Caspase-8 in Photodynamic Therapy-Hydrophilic/Lipophilic Tetra-α-(4-carboxyphenoxy) Phthalocyanine Zinc-Induced Apoptosis of Human Hepatocellular Carcinoma Bel-7402 Cells
Published 2014-01-01“…Our previous study showed that hydrophilic/lipophilic tetra-α-(4-carboxyphenoxy) phthalocyanine zinc- (TαPcZn-) mediated PDT (TαPcZn-PDT) inhibits the proliferation of human hepatocellular carcinoma Bel-7402 cells by triggering apoptosis and arresting cell cycle. …”
Get full text
Article